Serum apolipoprotein Al (apoAl) levels correlate with the risk of developing atherosclerosis. Previous studies have suggested that dehydroepiandrosterone (DHEA) lowers high-density lipoprotein (HDL)-cholesterol levels. We investigated whether or not DHEA may lower HDL-cholesterol levels by suppressing apoAl gene transcription in hepatocytes. ApoAl mRNA levels, assessed by Northern blotting, were suppressed in HepG2 cells treated with DHEA (34%) (10 mug/mL) or testosterone (36%) (T, 1 mug/mL). Estradiol alone (E-2, 1 mug/mL) had relatively little effect on apoAl mRNA levels, while E-2 in combination with DHEA prevented a decrease in apoAl mRNA levels compared to DHEA alone. To determine whether these effects were due to changes in apoAl gene transcription, HepG2 cells were transfected with a plasmid carrying the full-length promoter of the rat apoAI gene ligated into a chloramphenicol acetyltransferase (CAT) reporter construct. The plasmid pCMV.SPORT-beta-gal was included in each transfection to normalize the data to transfection efficiency. Cells were then cultured in the presence or absence of DHEA (10 mug/mL), T (1 mug/mL), 17alpha-methyltestosterone (MTT, 1 mug/mL), 5alpha-dihydrotestosterane (DHT, 1 mug/mL), E-2 (1 mug/mL), or a combination of DHEA plus E-2, T plus E-2, MTT plus E-2, and DHT plus E-2, for 24 hours. CAT activity, relative to beta-galactosidase activity, was reduced by 19.6%, 57.6%, 38.6%, and 54.6% with DHEA, T, DHT, and MTT addition, respectively. E-2 increased CAT activity by 43.8%. When the androgens (ie, DHEA, T, DHT, or MTT) were combined with E-2, apoAl promoter activity was suppressed. We conclude, therefore, that androgens downregulate apoAl promoter activity in the presence or absence of E-2. However, the changes in mRNA levels do not always reflect changes in promoter activity, suggesting that these steroids may have additional post-transcriptional effects on steady-state apoAl mRNA levels. It remains to be established if the transcriptional effects we observed are mediated through an androgen response element. Copyright (C) 2002 by W.B. Saunders Company.